Glycogen storage disease type 3

Autosomal recessive pathology affecting glycogen metabolism characterized by liver, heart and muscle (skeletal and cardiac) disorders.

Glycogen debranching enzyme (GDE) deficiency, or glycogenosis type 3 (GSD-3), is a glycogen storage disease characterized by severe muscle weakness and liver disease.

The disease is caused by mutations in the AGL gene, resulting in a deficit of GDE. The GDE enzyme acts together with the enzyme glycogen phosphorylase during the breakdown of glycogen (a substance our body uses to store glucose). The deficiency can affect the liver and muscles (subtype 3a) or only the liver (subtype 3b).

Its prevalence is estimated at approximately 1 case per 100,000 births (may be higher among North Africans).

Symptoms

GSD-3a is the most common subtype (85% of cases), usually develops in childhood and causes hepatomegaly or liver enlargement, growth retardation (short stature) and occasional seizures associated with low blood sugar levels. Hepatomegaly may disappear with adulthood. Muscle weakness appears slowly and progressively, affects both skeletal and cardiac muscle, and sometimes results in hypertrophic cardiomyopathy.

If the disease is not controlled in the long term, patients may develop complications such as type 2 diabetes, liver failure and hepatocellular carcinoma.

Disease management

Treatment consists of a specific diet rich in protein and complex carbohydrates, with continued nasogastric tube feeding in case of hypoglycemia or frequent meals and raw starch supplementation. In addition, in patients with cardiomyopathy and myopathy, there may be potential benefits in the use of medium-chain triglycerides and/or ketogenic supplements, with or without a high-protein diet. Patients are often supplemented with vitamin D and calcium to prevent osteoporosis.

Genes analyzed

AGL

Bibliography

Hijazi G, Paschall A, Young SP, et al . A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III. Mol Genet Metab Rep. 2021 Nov 11;29:100821.

Schreuder AB, Rossi A, Grünert SC, et al . Glycogen Storage Disease Type III. 2010 Mar 9 [updated 2022 Jan 6]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy